Vision Science Academy’s Post

🔬 Spotlight on Subspecialty Sessions at #EURETINA24 Our subspecialty sessions are designed to provide in-depth insights into the latest advancements and challenges across various retinal disciplines. Whether you’re focused on uveitis, retinal detachment, or AI in ophthalmology, there’s something for everyone. 📚 Explore Topics Like: - Posterior Uveitis: Diagnosis, Treatment & Complications - The Role of Multimodal Imaging in Retinal Diseases - Artificial Intelligence in Retinal Practice Swipe through the carousel to discover the sessions that match your interests and specialties. Each session is led by renowned experts, ensuring you gain the most up-to-date knowledge and practical insights. Don’t miss your chance to deepen your expertise and network with leaders in your field. Register now and be part of the future of retinal care. 🔗https://lnkd.in/dpN74qEq #EURETINA24 #Subspecialty #Retina #Ophthalmology #MedicalInnovation #ContinuingEducation

🌐🔬 From double-digit injections to potentially just a couple a year—join Dr. Prof. Marion Munk, M.D., Ph.D at European Society of Retina Specialists (EURETINA) 2024 as she delves into the transformative landscape of anti-VEGF therapy. Dr. Munk shares insights on how advancements in drug development are not only reducing the frequency of treatments but are also broadening the horizon with new modes of action targeting various aspects of retinal diseases. 💡👀 Explore how the shift towards drugs that address additional vascular endothelial growth factors and tackle underlying degenerative processes promises a future where treatments are not only longer-lasting but also more comprehensive. 🎙️ Stay tuned as we continue to bring you the latest groundbreaking discussions from the forefront of ophthalmology. #Euretina #Ophthalmology #EyeCare #RetinaSpecialist #MedicalInnovation #VisionHealth #EyeHealth #DigitalHealth #Retina #Ophthalmology #ClinicianLinkLive 

Have questions about glaucoma? It's not too late to register for our webinar, which is today from 4-5 p.m. ET. Hear from Dr. Tasneem P. Sharma, PhD, Assistant Professor of Ophthalmology at the Indiana University School of Medicine, about her research into optic nerve regeneration. Then ask glaucoma specialist, Dr. Delan Jinapriya your glaucoma questions. https://bit.ly/4aneSzM

Opthea announced the publication of a scientific review in the peer-reviewed journal Ophthalmology and Therapy. The publication, "Vascular Endothelial Growth Factor (VEGF) C and D Signaling Pathways as Potential Targets for the Treatment of neovascular (wet) AMD," underpins sozinibercept’s potential as a novel, first-in-class VEGF-C/D ‘trap’ to prevent blood vessel growth and vascular leakage in the retina and deliver superior visual outcomes in wet AMD patients when combined with standard-of-care anti-VEGF-A therapies. Read press release here: https://lnkd.in/ez62P5NG We want to thank the authors: Ian Leitch Mike Gerometta David Eichenbaum @Robert Finger Nathan Steinle Megan Baldwin Access the full publication: https://lnkd.in/eu2-_Bdt #Opthea #maculardegeneration #AMDResearch #wetAMD #ophthalmology #medicaleducation #biopharma #eyehealth #retinaspecialists #sozinibercept

One of the ways to stay ahead in ophthalmology clinical research is by keeping up with the latest NEI findings. At True North, we leverage this knowledge to design more effective trials. What recent eye research excites you? Share below. #eyeinnovation #clinicalresearch #contractresearchorganization  National Eye Institute (NEI)

This recent paper by these brilliant doctors and researchers evaluates the risk of death and subsequent vascular events in patients who experience retinal artery occlusion. Read the paper on JAMA Ophthalmology : https://buff.ly/3uqbYeA Listen to Dr. Prithvi Mruthyunjaya discuss TriNetX, the data network the team used in the study, on the JAMA Ophthalmology Author Interviews podcast: https://buff.ly/3OASVVE #Ophthalmology #OphthalmologyResearch #Research #Science #HealthCare #Medicine

👁️🔬 Dr. David Eichenbaum shares groundbreaking findings from his study on aflibercept high dose (EYLEA® HD (aflibercept) Injection HCP 8mg) in treating wet AMD. As the first real-world data set, the study reveals that while a significant portion of patients responded positively, extending treatment intervals, a segment still required more frequent care. This pivotal research highlights the importance of personalized medicine in ophthalmology, as responses vary widely among patients. Discover more about how these insights are shaping future treatment protocols. #ASRS2024 #Ophthalmology #MedicalLeadership #VisionaryInOphthalmology #MedicalInnovation #RetinaSpecialists #EyeCareInnovation #VisionScience #MedTech #HealthcareTrends #ClinicalResearch ASRS – American Society of Retina Specialists Bayer Bayer | Ophthalmology Saghar Bagheri MD PhD

🎥 Discover the future of personalized treatment with Dr. Peter Kaiser (Cleveland Clinic Lerner Research Institute) at COPHy Congress, as he discusses the integration of Home OCT and machine learning in patient care. Learn how this innovative approach allows for as-needed treatments, providing medication only when necessary, based on precise leakage detection. This method not only optimizes patient outcomes but also aligns with the patient's individual needs, ensuring they receive treatment at the exact right moment. Join Dr. Kaiser as he explores how technology is transforming the way we approach and deliver care in ophthalmology. #COPHY2024 #OphthalmologyInnovation #PatientCareProgress #OphthalmologyResearch #PatientCare #HealthcareEducation #retina #OphthalmologyFuture #medicalinnovation #glaucoma #Surgicalretina #uveitis #neuropathy

🌟 Dive into the insights of Dr. Anat Loewenstein as she discusses the findings of the Barometer Study - research made possible with the support of Bayer | Ophthalmology - a global survey aimed at understanding patient needs and healthcare practitioner awareness in ophthalmology. Discover the surprising revelations about clinic accessibility, staff knowledge gaps, and patient communication. Dr. Loewenstein's discussion sheds light on crucial areas needing attention in eye care, sparking conversations on how to enhance patient experience and staff education. Join us for this eye-opening session! #COPHY2024 #OphthalmologyResearch #PatientCare #HealthcareEducation #retina #OphthalmologyFuture #medicalinnovation #glaucoma #Surgicalretina #uveitis #neuropathy COPHy Congress Simrat Sodhi Anat Loewenstein Vision Academy

🌟 Excited to Share Our Latest Publication! 🌟 Thrilled to announce the publication of our big data study on intraocular pressure and gonioscopic findings in primary angle-closure disease in India. This research emphasizes the critical role of gonioscopy and the importance of measuring post-dilated intraocular pressure (IOP) in routine practice to identify at-risk cases early. It was indeed a tough journey, with many rejections along the way, but perseverance paid off! A huge thank you to my esteemed co-authors, Anthony Vipin Das and Sirisha Senthil, for their unwavering collaboration and expertise. This study wouldn’t have been possible without our combined efforts. Together, we aim to contribute to better outcomes in glaucoma care. For those interested in the details, the publication is now available in the latest issue of the International Journal of Ophthalmology. Let’s continue pushing the boundaries of ophthalmic research! 👁️🔬 #Ophthalmology #GlaucomaResearch #BigData #AngleClosure #Gonioscopy #PostDilatedIOP